Kambiz Etesami, MD

Dr. Etesami is an Assistant Professor of Clinical Surgery in the Division of Hepatopancreaticobiliary Surgery and Abdominal Organ Transplantation at the Keck School of Medicine of USC. 

Dr. Etesami specializes in adult and pediatric liver, bowel, kidney and pancreas transplantation.  He additionally performs HPB surgery (relating to the liver, pancreas, and biliary systems), incorporating both traditional and minimally invasive techniques for a variety of benign and malignant conditions.  
His medical interests include the expansion of organ availability and transplantation with a focus on living donation and maximized utilization of extended criteria organs, and management of advanced hepatobiliary & pancreatic neoplasia.  

He is an active member of the American Society of Transplant Surgeons and is an associate fellow with the American College of Surgeons.

• Response Regarding Application of the CHALF Score in Pediatric Acute Liver Failure Transplantation. 2024 Apr 01; 108(4):e66-e67. . View in PubMed
• CHALF Score: A Novel Tool to Rapidly Risk Stratify Children in Need of Liver Transplant Evaluation During Acute Liver Failure Transplantation. 2023 Oct 23. . View in PubMed
• Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation Liver Transpl. 2023 Feb 01; 29(2):134-144. . View in PubMed
• Evaluation of technical urinary tract complications in kidney transplantation recipients with a prolonged dialysis history Surgery. 2023 08; 174(2):136-141. . View in PubMed
• Living donor liver paired exchange between pediatric and adult recipients due to donor graft size mismatch Am J Transplant. 2023 03; 23(3):440-442. . View in PubMed
• Liver Transpl 2022 Aug 21; 134-144. . View in PubMed
• Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation Liver Transpl. 2022 05; 28(5):843-854. . View in PubMed
• Immunologic benefits of maternal living donor allografts in pediatric liver transplantation: fewer rejection episodes and no evidence of de novo allosensitization Pediatr Transplant. 2022 05; 26(3):e14197. . View in PubMed
• Re: Manuscript titled, “Liver transplantation for sickle cell disease: a systematic review” HPB (Oxford). 2021 07; 23(7):1135. . View in PubMed
• Surgical shunts for extrahepatic portal vein obstruction in pediatric patients: a systematic review HPB (Oxford). 2021 05; 23(5):656-665. . View in PubMed
• Biliary Internal Stents and Biliary Complications in Adult Liver Transplantation Transplant Proc. 2021 Jan-Feb; 53(1):171-176. . View in PubMed
• Pediatric kidney transplantation, a technical update Curr Opin Organ Transplant. 2021 08 01; 26(4):356-359. . View in PubMed
• Pediatric kidney transplantation in the United States Curr Opin Organ Transplant. 2020 08; 25(4):343-347. . View in PubMed
• Should living donor liver transplant selection be subject to the same restrictions as deceased donor transplant? Curr Opin Organ Transplant. 2020 02; 25(1):47-51.. View in PubMed
• The Increasingly Limited Basis for Portal Venous Pressure Modulation in Living Donor Liver Transplantation Liver Transpl. 2018 11; 24(11):1506-1507. . View in PubMed
• Reno-portal shunt for liver transplant, an alternative inflow for recipients with grade III-IV portal vein thrombosis: Tips for a better outcome Int J Surg Case Rep. 2017; 41:251-254. . View in PubMed
• Hospital Readmissions After Intestinal and Multivisceral Transplantation Transplant Proc. 2016 Jul-Aug; 48(6):2186-91. . View in PubMed
• Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge World J Hepatol. 2015 Nov 18; 7(26):2696-702. . View in PubMed

• Emamaullee, Juliet
• Genyk, Yuri
• Terrault, Norah